A carregar...

MET and VEGF: synergistic targets in castration-resistant prostate cancer

Recent advances in the treatment of prostate cancer have resulted in improved outcomes, including longer survival, but new options are needed for treating patients with castration-resistant disease, particularly in the presence of bone metastasis. Data from preclinical models and clinical biomarker...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Transl Oncol
Main Authors: Aftab, Dana T., McDonald, Donald M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4422050/
https://ncbi.nlm.nih.gov/pubmed/21975330
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12094-011-0719-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!